GRANT ANNOUNCEMENT: FY12 Funding Opportunities for GWI Medical Research

Source:  Public Affairs Email, Congressionally Directed Medical Research Program (CDMRP), U.S. Army Medical Research & Materiel Command (USAMRMC), U.S. Department of Defense (DoD)

********************

FY12 Department of Defense Gulf War Illness Research Program Funding Opportunities

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10 million to the Department of Defense Gulf War Illness Research Program (GWIRP) to support innovative, high-impact research into Gulf War Illness. The Department of Defense Gulf War Illness Research Program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP). 

Please inform researchers interested in Gulf War Illness research that three award mechanisms have been released.  FY12 GWIRP program announcements and general application instructions are available at:   

http://cdmrp.army.mil/funding/gwirp.shtml

1) Investigator-Initiated Research Award - Pre-application is due April 9, 2012 Independent investigators at all academic levels are eligible to apply.

• Supports new ideas in basic and clinical developmental research focusing on Gulf War Illness (GWI).
• Preliminary data are not required, and if provided, do not necessarily have to come from the GWI research field.
• Clinical trials are not allowed under this mechanism.
• The maximum allowable funding for the entire period of performance is $600,000 for direct costs.
• The maximum period of performance is 3 years.
• More cost-effective studies not requesting the full funding amount are encouraged.

2) Innovative Treatment Evaluation Award - Pre-application is due April 9, 2012 Independent investigators at all academic levels are eligible to apply.

• Supports exploratory or small-scale studies evaluating potential treatments not previously studied in GWI.
• Pilot Phase II or Phase I/II trial combinations are permitted.
• Preliminary data are not required, though proposed studies must be supported by logical rationale.
• The maximum allowable funding for the entire period of performance is $450,000 for direct costs.
• The maximum period of performance is 3 years.
• More cost-effective studies not requesting the full funding amount are encouraged.

3) Clinical Trial Award - Pre-application is due April 9, 2012 Independent Investigators at all academic levels Supports larger, more definitive Phase II or III clinical trials focusing on treatments for GWI.

• Preliminary/preclinical data are required, indicating potential substantial benefit for veterans with GWI.
• Pilot or exploratory studies focusing on treatments lacking preclinical/preliminary data should submit to the Innovative Treatment Evaluation Award.
• The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance is 4 years.
• More cost-effective studies not requesting the full funding amount are encouraged.

ALL:  All applications must conform to the final program announcements and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism can also be found by clicking the hyperlinked award mechanism titles, above. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.  Funding opportunities for breast cancer, ALS, and bone marrow failure medical research are also available at this link.  

 A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of April 9, 2012. Applications must be submitted through the federal government’s single-entry portal, Grants.gov.

Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

For additional information regarding eligibility, application submission, and questions about the program itself please contact the CDMRP helpdesk at help@CDMRP.org or call (301) 682-5507.

If you would like to request direct email messages from CDMRP, please contact CDMRP.PublicAffairs@amedd.army.mil with your email address.